Featured content in this Issue: Companies and candidates mentioned in this Bulletin: Incannex Healthcare, PSX-001, MindMed, MM-120, Cybin, CYB004, Compass Pathways, GH Research, GH001, Enveric Biosciences, atai Life Sciences, aNUma. This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to learn more, or sign in to your account.


Previous articlePsychedelic Integration: How to Weave Your Experiences Into Daily Life
Next articlePT491 – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic Compounds